synthesi
dideoxi
fluoro
ketopyranonucleosid
analogu
n
benzoyl
cytosin
n
benzoyl
cytosin
detrityl
analogu
respect
describ
condens
peracetyl
silyl
n
benzoyl
cytosin
follow
select
deprotect
isopropyliden
afford
compound
routin
deoxygen
posit
follow
deprotectionselect
reprotect
sequenc
afford
partial
trityl
dideoxi
nucleosid
cytosin
upon
oxid
free
hydroxyl
group
posit
furnish
desir
trityl
ketonucleosid
equilibrium
hydrat
form
compound
start
materi
synthesi
dideoxi
fluoro
ketopyranonucleosid
similarli
sever
subsequ
protect
deprotect
step
well
routin
deoxygen
posit
follow
oxid
free
hydroxyl
group
posit
partial
trityl
dideoxi
nucleosid
yield
desir
carbonyl
compound
equilibrium
hydrat
form
final
trityl
remov
provid
unprotect
analogu
equilibrium
gemdiol
form
none
compound
show
inhibitori
activ
wide
varieti
dna
rna
virus
subtox
concentr
except
highli
effici
rotaviru
infect
nucleosid
also
exhibit
cytostat
activ
cell
variou
cancer
brducel
cycl
analysi
reveal
mechan
cytostat
activ
may
relat
delay
phase
initi
program
cell
death
synthesi
dideoxi
fluoro
ketopyranonucleosid
analogu
n
benzoyl
cytosin
n
benzoyl
cytosin
detrityl
analogu
respect
describ
condens
peracetyl
silyl
n
benzoyl
cytosin
follow
select
deprotect
isopropyliden
afford
compound
routin
deoxygen
posit
follow
deprotectionselect
reprotect
sequenc
afford
partial
trityl
dideoxi
nucleosid
cytosin
upon
oxid
free
hydroxyl
group
posit
furnish
desir
trityl
ketonucleosid
equilibrium
hydrat
form
compound
start
materi
synthesi
dideoxi
fluoro
ketopyranonucleosid
similarli
sever
subsequ
protect
deprotect
step
well
routin
deoxygen
posit
follow
oxid
free
hydroxyl
group
posit
partial
trityl
dideoxi
nucleosid
yield
desir
carbonyl
compound
equilibrium
hydrat
form
final
trityl
remov
provid
unprotect
analogu
equilibrium
gemdiol
form
none
compound
show
inhibitori
activ
wide
varieti
dna
rna
virus
subtox
concentr
except
highli
effici
rotaviru
infect
nucleosid
also
exhibit
cytostat
activ
cell
variou
cancer
brducel
cycl
analysi
reveal
mechan
cytostat
activ
may
relat
delay
phase
initi
program
cell
death
elsevi
masson
sa
right
reserv
nucleosid
structur
modul
nucleic
acid
therefor
fundament
import
live
system
play
major
role
treat
tumor
viru
either
select
inhibitor
certain
obligatori
enzym
cancer
viral
replic
nucleic
acid
chain
termin
interrupt
replic
cancer
cell
viru
pyrimidin
nucleosid
attract
increas
attent
result
import
physiolog
biogenet
properti
among
nucleosid
bear
cytosin
base
develop
potent
antitumor
agent
effect
leukemia
lymphoma
also
wide
varieti
solid
tumor
vitro
well
vivo
last
decad
nucleosid
sixmemb
carbohydr
moieti
evalu
potenti
antivir
antibiot
antioxid
properti
build
block
nucleic
acid
synthesi
seri
sixmemb
nucleosid
analogu
ketonucleosid
prove
key
intermedi
synthet
biosynthet
process
exhibit
interest
antitumor
antivir
properti
nucleosid
known
inhibit
dna
rna
protein
synthesi
interact
sulfhydryl
group
cellular
protein
enzym
found
highli
cytotox
vitro
exert
power
inhibitori
action
leukemia
vivo
view
fact
take
account
introduct
fluorin
sugar
moieti
nucleosid
enhanc
activ
previous
synthes
variou
unsatur
fluoro
ketopyranonucleosid
analogu
prove
effici
tumor
growth
inhibitor
show
promis
potenti
combat
rotavir
infect
thu
continu
studi
synthesi
sugarmodifi
pyranonucleosid
base
interest
biolog
properti
deoxyhexopyranos
nucleosid
decid
design
synthes
new
class
fluoro
ketopyranonucleosid
analogu
fluorin
nucleosid
n
benzoyl
cytosin
order
assess
biolog
activ
chemic
synthesi
biolog
activ
compound
present
herein
two
differ
synthet
rout
investig
synthesi
titl
compound
n
benzoyl
cytosin
n
benzoyl
cytosin
first
reaction
scheme
condens
scheme
silyl
n
benzoyl
cytosin
follow
select
deprotect
specif
acetal
use
n
ndimethylformamid
dmf
gave
isopropyliden
deriv
phenoxythiocarbonyl
commonli
use
condit
phenyl
chlorothionoform
phoc
cl
excess
amount
dmap
acetonitril
afford
ophenoxythiocarbonyl
deriv
yield
deoxygen
compound
carri
trinbutyltin
hydrid
bu
snh
afford
deoxynucleosid
yield
oisopropyliden
group
remov
upon
treatment
aqueou
trifluoroacet
acid
tfa
select
protect
primari
hydroxyl
group
trityl
group
yield
partial
protect
deriv
yield
oxid
fluoro
trityl
dideoxi
precursor
perform
pyridinium
dichrom
pdc
acet
anhydrid
ac
afford
keto
form
n
benzoyl
cytosin
equilibrium
hydrat
analogu
ratio
clearli
determin
integr
relat
h
nmr
signal
appear
presenc
electronwithdraw
fluorin
atom
carbonyl
caus
easi
hydrat
gemdiol
format
final
detrityl
ch
cl
formic
acid
led
correspond
dideoxi
carbonyl
compound
n
benzoyl
cytosin
equilibrium
gemdiol
compound
start
materi
synthesi
n
benzoyl
cytosin
scheme
acetyl
nucleosid
follow
deisopropyliden
final
select
trityl
primari
hydroxyl
group
gave
compound
convert
deoxi
nucleosid
analogu
via
ophenoxythiocarbonyl
deriv
similar
methodolog
describ
deacetyl
perform
use
naohethanol
etoh
pyridin
afford
compound
good
yield
oxid
free
hydroxyl
group
posit
sugar
moieti
nucleosid
pdcac
afford
desir
keto
form
n
benzoyl
cytosin
equilibrium
hydrat
analogu
ratio
clearli
determin
integr
relat
nmr
signal
final
deprotect
primari
hydroxyl
group
perform
use
ch
cl
formic
acid
furnish
keton
equilibrium
gemdiol
mention
attempt
remov
benzoyl
group
target
nucleosid
analogu
unsuccess
degrad
product
obtain
compound
well
character
nmr
uv
spectroscopi
mass
spectrometri
element
analysi
h
nmr
spectrum
show
doublet
ppm
j
hz
doublet
doublet
doublet
ppm
j
f
hz
j
j
hz
assign
proton
respect
keto
compound
well
doublet
ppm
j
hz
doublet
doublet
doublet
ppm
j
f
hz
j
hz
j
hz
assign
proton
respect
gemdiol
similarli
h
nmr
spectrum
signal
keto
gemdiol
form
appear
two
sharp
singlet
ppm
respect
signal
appear
two
doublet
doublet
doublet
ppm
j
f
hz
j
j
b
hz
ppm
j
f
hz
j
hz
j
b
hz
respect
thu
case
h
nmr
spectra
confirm
equilibrium
keto
gemdiol
form
howev
h
nmr
spectra
well
methanold
cd
od
solut
show
doublet
ppm
j
hz
assign
proton
sharp
singlet
ppm
assign
proton
signal
appear
doublet
doublet
doublet
compound
ppm
j
f
hz
j
hz
j
hz
ppm
j
f
hz
j
hz
j
b
hz
respect
indic
presenc
gemdiol
form
exclus
final
target
compound
character
absenc
proton
proton
respect
h
nmr
spectra
result
antivir
assay
rotaviru
newli
synthes
dideoxi
fluoropyranonucleosid
analogu
b
detrityl
analogu
respect
summar
compar
azt
tabl
neutral
assay
found
neutral
rotaviru
attach
cell
concentr
mm
vide
ic
compar
azt
mm
similar
result
observ
inhibit
infect
follow
viru
attach
tabl
analogu
actual
potent
congen
produc
effect
much
lower
concentr
mm
treatment
b
interestingli
detrityl
analogu
although
activ
antivir
assay
seem
exert
action
differ
mechan
contrast
compound
analogu
show
antivir
potenc
specul
posit
keto
group
ring
skeleton
compound
b
critic
inhibit
rotaviru
replic
cell
well
neutral
rotaviru
attach
accord
antivir
assay
use
suggest
test
compound
show
specif
activ
rotaviru
capabl
inhibit
rotaviru
infect
cell
significantli
lower
concentr
azt
compar
recent
report
unsatur
fluoro
ketopyranonucleosid
analogu
dideoxi
fluoro
ketopyranonucleosid
present
herein
found
potent
thu
suitabl
candid
antirotaviru
therapi
thu
suggest
incorpor
carboncarbon
doubl
bond
ring
system
dideoxi
fluoro
ketopyranonucleosid
mark
reduc
effect
antivir
activ
seem
structur
featur
carbohydr
moieti
influenc
abil
nucleosid
analogu
particip
antivir
mechan
cytotox
potenti
compound
b
studi
normal
human
intestin
cell
hel
human
lung
fibroblast
cell
seri
variou
human
tumor
cell
human
colon
adenocarcinoma
deriv
cell
gastric
cancer
deriv
ag
cell
epitheli
breast
cancer
deriv
cell
vero
african
green
monkey
cell
hela
human
cervix
carcinoma
cell
growth
inhibit
cell
caus
new
compound
measur
determin
growth
inhibitori
concentr
ic
result
summar
tabl
compar
valu
obtain
test
compound
cytotox
malign
cell
differ
origin
substanti
tumor
select
index
tabl
test
dideoxi
fluoropyranonucleosid
analogu
compound
exhibit
noteworthi
cytotox
good
select
indic
particularli
ag
cell
comparison
control
compound
compound
effect
ag
cell
compound
effect
ag
cell
result
obtain
clear
new
compound
show
select
toward
specif
tumor
cell
line
unpreced
exampl
literatur
demonstr
mode
inhibitori
action
especi
target
enzym
carcinogen
cell
alway
similar
even
among
nucleosid
antimetabolit
nucleosid
base
growth
inhibit
assay
compound
capabl
inhibit
growth
malign
cell
rang
compar
ic
tabl
spite
fact
differ
observ
among
test
compound
growth
inhibit
activ
colon
carcinoma
cell
analogu
strong
inhibitor
malign
cell
growth
cancer
type
convers
previous
report
unsatur
fluoro
ketopyranonucleosid
analogu
new
dideoxi
fluoropyranonucleosid
especi
compound
show
satisfactori
similar
cytotox
cell
cell
appear
exist
carboncarbon
doubl
bond
sugar
residu
seem
structur
prerequisit
cytotox
growth
inhibit
activ
contrari
presenc
ketofluoro
system
indispens
mani
mechan
implic
resist
sensit
pharmacokinet
resist
decreas
accumul
activ
metabolit
alter
effect
thymidyl
synthas
ts
fluoropyrimidin
treatment
lead
cell
cycl
arrest
paramet
cell
cycl
distribut
also
use
predict
ketonucleosid
sensit
order
find
whether
mechan
antitumor
activ
andor
resist
dideoxi
fluoro
ketopyranonucleosid
analogu
similar
mechan
action
influenc
cell
cycl
distribut
induct
apoptosi
studi
brducel
cycl
analysi
result
clearli
show
cell
line
equitox
treatment
result
increas
percentag
cell
decreas
cell
phase
tabl
compound
fig
howev
brdu
analysi
show
cell
cycl
delay
took
place
specif
interfac
previous
report
tabl
fig
exposur
cancer
cell
compound
led
brduposit
cell
label
index
li
increas
howev
li
modif
relat
phase
accumul
real
enhanc
sphase
fraction
fact
brdu
analysi
show
cell
determin
analysi
compos
brduposit
brduneg
cell
subpopul
fig
subpopul
distinguish
use
analysi
alon
view
consequ
cell
fraction
abl
incorpor
brdu
maintain
dna
content
fraction
consid
phase
analysi
wherea
includ
label
subpopul
brdu
analysi
thu
cell
perform
repair
synthesi
dna
net
dna
increas
would
includ
li
score
could
still
dna
content
indistinguish
cell
synchron
cell
caus
delay
may
relat
program
cell
death
initi
induc
delay
repres
apoptosi
involv
treatment
sensibl
actual
peak
repres
apoptot
cell
detect
use
flow
cytometri
alreadi
untreat
cell
enhanc
cell
treat
compound
apoptot
activ
test
compound
observ
cell
line
suggest
ketonucleosideinduc
apoptosi
mediat
mechan
find
could
import
implic
clinic
set
sinc
mani
tumor
alter
mutat
shown
associ
poor
respons
chemotherapi
summari
newli
synthes
fluorin
nucleosid
n
benzoyl
cytosin
show
good
antivir
activ
toward
rotaviru
low
concentr
compar
azt
orand
previous
synthes
correspond
unsatur
fluoro
ketopyranonucleosid
analogu
specul
modif
sugar
compon
import
role
case
furthermor
newli
synthes
compound
show
antitumor
activ
test
cell
line
especi
gastric
cancer
deriv
ag
cell
compound
even
cytotox
cancer
cell
line
test
control
compound
compound
b
also
show
effect
antitumor
activ
growth
suppress
colon
carcinoma
cell
previous
synthes
correspond
unsatur
fluoro
ketopyranonucleosid
analogu
also
shown
use
flow
cytometr
brducel
cycl
analysi
mechan
antitumor
activ
newli
synthes
compound
may
relat
delay
program
cell
death
initi
moreov
result
indic
compound
may
strong
implic
clinic
set
especi
treatment
tumor
poorli
respons
exist
chemotherapi
agent
view
consider
increas
evid
suggest
close
correl
biolog
activ
presenc
afluorocarbonyl
moieti
howev
mechan
action
newli
synthes
nucleosid
thu
far
unclear
would
therefor
interest
explor
structureact
relationship
modifi
base
part
keep
remov
benzyl
part
well
replac
fluorin
group
differ
chemic
entiti
melt
point
record
meltemp
apparatu
uncorrect
thinlay
chromatographi
tlc
perform
merck
precoat
plate
reaction
monitor
tlc
silica
gel
detect
uv
light
nm
char
sulfur
acid
flash
column
chromatographi
perform
use
silica
gel
mesh
merck
h
f
c
nmr
spectra
obtain
room
temperatur
bruker
spectromet
mhz
respect
use
cdcl
cd
od
intern
tetramethylsilan
tm
h
c
intern
trifluorotoluen
tft
f
chemic
shift
express
part
per
million
follow
abbrevi
use
singlet
br
broad
singlet
doublet
ddd
doublet
doublet
doublet
dtr
doublet
triplet
dq
doublet
quartet
multiplet
mass
spectra
obtain
micromass
platform
lc
esim
optic
rotat
measur
use
autopol
polarimet
reaction
carri
dri
solvent
ch
cl
distil
phosphor
pentoxid
store
molecular
siev
ch
cn
toluen
distil
calcium
hydrid
store
molecular
siev
pyridin
store
pellet
potassium
hydroxid
reaction
sensit
oxygen
moistur
carri
nitrogen
atmospher
stir
min
room
temperatur
reaction
quench
ad
water
ml
solvent
remov
reduc
pressur
obtain
residu
dissolv
etoac
ml
wash
water
ml
dri
anhydr
magnesium
sulfat
mgso
evapor
reduc
pressur
purifi
flash
column
chromatographi
use
ethyl
acetatenhexan
eluant
afford
yellow
syrup
yield
g
compound
g
mmol
coevapor
three
time
anhydr
toluen
dissolv
toluen
ml
degass
nitrogen
min
solut
ad
bu
snh
ml
mmol
cyclohexan
carbonitril
g
mmol
mixtur
heat
c
h
cool
room
temperatur
mixtur
evapor
residu
purifi
flash
column
chromatographi
use
ethyl
acetatenhexan
solut
compound
g
mmol
dri
pyridin
ml
ad
triphenylmethyl
chlorid
g
mmol
catalyt
amount
dmap
mixtur
stir
c
h
concentr
purif
flash
column
chromatographi
use
ethyl
acetatenhexan
mixtur
g
mmol
dri
coevapor
toluen
pdc
g
mmol
ac
ml
mmol
reflux
c
dri
ch
cl
ml
min
cool
ethyl
acet
ml
ad
result
slurri
transfer
top
silicagel
column
pack
ethyl
acet
solut
filter
column
wash
ethyl
acet
ml
product
elut
complet
solvent
evapor
residu
render
free
ac
pyridin
coevapor
dri
toluen
final
purif
flash
column
chromatographi
use
ethyl
acetatenhexan
compound
g
mmol
dissolv
mixtur
ch
cl
ml
formic
acid
ml
solut
stir
min
room
temperatur
dilut
toluen
codistil
sever
time
solvent
avoid
ester
format
concentr
residu
purifi
flash
column
chromatographi
use
ethyl
acetatemethanol
eluant
compound
obtain
white
powder
yield
g
r
f
compound
mmol
dissolv
etohpyridin
ml
naoh
ml
ad
mixtur
stir
h
c
amberlit
h
ad
neutral
base
suspens
filter
resin
wash
etoh
pyridin
ml
filtrat
evapor
solid
residu
purifi
flash
column
chromatographi
use
ethyl
acet
eluant
obtain
yellowish
foam
yield
cytosin
deriv
synthes
methodolog
describ
synthesi
dideoxi
fluoro
ketonucleosid
freshli
prepar
steril
dimethyl
sulfoxid
dmso
concentr
mgml
final
concentr
dmso
cell
cultur
medium
solut
protect
light
azt
retrovir
glaxosmithklin
usa
drug
use
antiretrovir
therapi
art
use
standard
compound
biolog
experi
prepar
way
dideoxi
fluoro
ketonucleosid
fluorouracilum
lederl
arzeinmittel
gmbh
brd
drug
use
antitumor
therapi
use
standard
compound
control
growth
inhibit
cytotox
assess
compound
prepar
way
dideoxi
fluoro
ketonucleosid
rotaviru
rf
strain
propag
cell
presenc
trypsin
mg
per
ml
dmem
describ
previous
supernat
contain
viru
collect
flask
cytopath
effect
cpe
observ
h
c
microscopi
clarifi
centrifug
viru
store
c
use
potenti
antivir
activ
newli
synthes
compound
test
rotaviru
investig
inhibit
infect
follow
viru
attach
wash
monolay
cell
first
incub
rotaviru
h
c
atmospher
co
time
viru
attach
cell
membran
receptor
incub
remain
viru
wash
dmem
without
supplement
monolay
treat
immedi
test
compound
azt
ad
serial
dilut
initi
concentr
mgml
h
incub
rotaviru
plate
stain
crystal
violet
etoh
rins
water
destain
vv
acet
acid
measur
result
express
dilut
mean
ratio
aesd
absorb
virusinfect
well
n
control
viru
infect
well
n
inhibitori
concentr
ic
test
compound
obtain
concentrationeffect
curv
b
neutral
viru
solut
attach
dilut
test
compound
azt
initi
concentr
mgml
first
coincub
rotaviru
dmem
supplement
trypsin
h
prior
infect
cell
monolay
c
co
residu
viral
infect
measur
h
post
infect
rotaviru
alon
treat
way
control
h
incub
plate
stain
crystal
violet
etoh
rins
water
destain
vv
acet
acid
measur
result
express
dilut
mean
ratio
aesd
absorb
virusinfect
well
n
control
viru
infect
well
n
inhibitori
concentr
ic
test
compound
obtain
concentrationeffect
curv
cell
cell
breast
carcinoma
gastric
cancer
deriv
ag
cell
cell
per
plate
seed
plate
treat
compound
azt
serial
dilut
compound
initi
concentr
mgml
cell
incub
c
humidifi
incub
h
plate
stain
crystal
violet
etoh
rins
water
destain
vv
acet
acid
measur
result
express
dilut
mean
ratio
aesd
absorb
treat
well
n
control
well
n
cytotox
concentr
cc
test
compound
obtain
concentrationeffect
curv
perform
cell
line
modifi
method
describ
previous
briefli
plate
six
well
dilut
compound
initi
concentr
mg
ml
appli
cellswel
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
incub
perform
c
humidifi
incub
day
coloni
count
well
result
express
dilut
mean
ratio
aesd
coloni
number
treat
well
n
control
well
n
growth
inhibitori
concentr
ic
test
compound
obtain
concentrationeffect
curv
cell
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
seed
plate
cell
per
well
treat
compound
concentr
yield
growth
inhibit
ic
left
untreat
cell
incub
c
humidifi
incub
h
last
hour
incub
cell
puls
mm
brdu
solut
sampl
flow
cytometri
process
use
fitcbrdu
flow
kit
bd
bioscienc
accord
manufactur
protocol
flow
cytometri
perform
bd
lsr
ii
bd
bioscienc
instrument
data
analyz
use
facsdiva
softwar
bd
bioscienc
cell
gate
accord
fsc
versu
ssc
scatter
properti
bivari
distribut
brdu
content
fitc
versu
dna
content
analyz
cell
cycl
distribut
phase
apoptot
sub
cell
determin
accord
gate
repres
fig
also
subpopul
correspond
brduposit
cell
contain
dna
determin
label
index
li
correspond
phase
percentag
brduposit
cell
fig
compound
evalu
follow
virus
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
lyon
g
vaccinia
viru
lederl
strain
respiratori
syncyti
viru
rsv
strain
long
vesicular
stomat
viru
vsv
coxsacki
sindbi
punta
toro
influenza
viru
type
type
b
felin
corona
viru
antivir
antihiv
assay
base
inhibit
virusinduc
cytopath
human
embryon
lung
hel
fibroblast
african
green
monkey
cell
vero
human
epitheli
cervix
carcinoma
cell
hela
crandel
felin
kidney
cell
cfkc
madindarbi
canin
kidney
cell
mdck
briefli
confluent
cell
cultur
microtit
plate
inocul
viru
ccid
viru
dose
infect
cell
cultur
h
adsorpt
period
residu
viru
remov
cell
cultur
incub
presenc
vari
concentr
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopath
human
cem
cell
cultur
cell
ml
infect
iii
b
rod
per
ml
seed
mlwell
microtit
plate
contain
appropri
dilut
test
compound
day
incub
c
syncytia
format
examin
microscop
cem
cell
cultur
cytostat
concentr
mdck
crfk
cell
calcul
cc
compound
concentr
requir
reduc
cell
prolifer
rel
number
cell
untreat
control
cc
valu
estim
graphic
plot
number
cell
percentag
control
function
concentr
test
compound
altern
cytotox
test
compound
hel
vero
hela
cell
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
